55Indexed trials
mesh condition
Psychotic Disorders
Intelligence
Psychotic Disorders intelligence: 55 indexed trials, 9 recruiting studies, 47 sponsors across 33 countries.
9Recruiting
47Sponsors
33Countries
Leading sponsors
University of North Carolina, Chapel Hill40 recruiting
Fundación Marques de Valdecilla20 recruiting
University of Minnesota20 recruiting
VA Office of Research and Development21 recruiting
University of Oxford21 recruiting
George Washington University20 recruiting
Centre Psychothérapique de Nancy11 recruiting
Central Hospital, Nancy, France10 recruiting
AstraZeneca10 recruiting
Columbia University11 recruiting
Corcept Therapeutics10 recruiting
Christina Andreou10 recruiting
Geographic activity
United States28trials
France5trials
Canada5trials
Germany4trials
Spain4trials
Switzerland3trials
United Kingdom3trials
South Korea2trials
Italy2trials
Bulgaria2trials
Australia2trials
Poland2trials
Leading interventions
risperidone4trials
Risperidone2trials
Aripiprazole2trials
tDCS2trials
olanzapine2trials
Cannabidiol1trials
CRT and Social Cognition1trials
Aripiprazole or Perphenazine1trials
DAR-100A1trials
Control games1trials
Digital: Kiso Mind App1trials
Autistic spectre disorder screening1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.